NEW YORK (GenomeWeb News) – The National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health has given the Albert Einstein College of Medicine of Yeshiva University nearly $10.2 million through two new grants to fund its Diabetes Research and Training Center (DRTC), which conducts genetics and molecular research, among other disciplines.
The DRTC has six cores, including ones focused on epigenomics, metabolomics, flow cytometry, animal physiology, analytical imaging, and hormone assay research.
In addition to the five-year, $9.5 million grant from the National Institute of Digestive and Kidney Diseases, the new funding includes a $632,000 supplemental grant for equipment and pilot and feasibility studies awarded through the American Recovery and Reinvestment Act.
"The ultimate goal of these studies is to develop new therapies for the prevention or treatment of diabetes," Jeffrey Pessin, director of the DRTC and a professor of medicine and of molecular pharmacology at Einstein, said in a statement.
Some of the DRTC's research efforts are conducted at the Michael F. Price Center for Genetic and Translational Medicine/Harold and Muriel Block Research Pavilion, a 223,000-square-feet facility that was completed in 2008 at Yeshiva's campus in Bronx, NY.